Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers
Phase 1
Terminated
- Conditions
- Diabetic Foot Ulcers
- Interventions
- First Posted Date
- 2014-01-15
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- Royer Biomedical, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT02036528
- Locations
- 🇺🇸
Georgetown University Hospital Center, Washington, District of Columbia, United States
🇺🇸GF Professional Research, Corp., Miami Lakes, Florida, United States
🇺🇸Florida Medical Center & Research, Inc., Miami, Florida, United States
News
No news found